Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate ...
Prostate cancer (PCa) is one of the most common malignancies diagnosed among men and is the second leading cause of cancer-related death. Despite recent advancements in early diagnosis of PCa, androgen deprivation therapy (ADT) remains the most common …